1. Home
  2. SILO vs MITQ Comparison

SILO vs MITQ Comparison

Compare SILO & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • MITQ
  • Stock Information
  • Founded
  • SILO 2010
  • MITQ N/A
  • Country
  • SILO United States
  • MITQ United States
  • Employees
  • SILO N/A
  • MITQ N/A
  • Industry
  • SILO Apparel
  • MITQ Telecommunications Equipment
  • Sector
  • SILO Consumer Discretionary
  • MITQ Telecommunications
  • Exchange
  • SILO Nasdaq
  • MITQ Nasdaq
  • Market Cap
  • SILO 8.8M
  • MITQ 8.0M
  • IPO Year
  • SILO N/A
  • MITQ 2021
  • Fundamental
  • Price
  • SILO $1.54
  • MITQ $0.70
  • Analyst Decision
  • SILO
  • MITQ
  • Analyst Count
  • SILO 0
  • MITQ 0
  • Target Price
  • SILO N/A
  • MITQ N/A
  • AVG Volume (30 Days)
  • SILO 600.9K
  • MITQ 4.5M
  • Earning Date
  • SILO 02-18-2025
  • MITQ 02-18-2025
  • Dividend Yield
  • SILO N/A
  • MITQ N/A
  • EPS Growth
  • SILO N/A
  • MITQ N/A
  • EPS
  • SILO N/A
  • MITQ N/A
  • Revenue
  • SILO $72,102.00
  • MITQ $18,756,000.00
  • Revenue This Year
  • SILO $1.86
  • MITQ N/A
  • Revenue Next Year
  • SILO N/A
  • MITQ N/A
  • P/E Ratio
  • SILO N/A
  • MITQ N/A
  • Revenue Growth
  • SILO N/A
  • MITQ N/A
  • 52 Week Low
  • SILO $0.77
  • MITQ $0.42
  • 52 Week High
  • SILO $4.50
  • MITQ $1.55
  • Technical
  • Relative Strength Index (RSI)
  • SILO 52.57
  • MITQ 48.16
  • Support Level
  • SILO $1.56
  • MITQ $0.68
  • Resistance Level
  • SILO $1.89
  • MITQ $0.76
  • Average True Range (ATR)
  • SILO 0.19
  • MITQ 0.05
  • MACD
  • SILO -0.05
  • MITQ -0.01
  • Stochastic Oscillator
  • SILO 27.12
  • MITQ 25.97

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

Share on Social Networks: